DE3770465D1 - Verwendung von zinn-protoporphyrin und zinn-mesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis. - Google Patents
Verwendung von zinn-protoporphyrin und zinn-mesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis.Info
- Publication number
- DE3770465D1 DE3770465D1 DE8888900434T DE3770465T DE3770465D1 DE 3770465 D1 DE3770465 D1 DE 3770465D1 DE 8888900434 T DE8888900434 T DE 8888900434T DE 3770465 T DE3770465 T DE 3770465T DE 3770465 D1 DE3770465 D1 DE 3770465D1
- Authority
- DE
- Germany
- Prior art keywords
- tin
- mesoporphyrine
- protoporphyrine
- producing
- medicinal product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 201000004681 Psoriasis Diseases 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- LLDZJTIZVZFNCM-UHFFFAOYSA-J 3-[18-(2-carboxyethyl)-8,13-diethyl-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid;dichlorotin(2+) Chemical compound [H+].[H+].[Cl-].[Cl-].[Sn+4].[N-]1C(C=C2C(=C(C)C(=CC=3C(=C(C)C(=C4)N=3)CC)[N-]2)CCC([O-])=O)=C(CCC([O-])=O)C(C)=C1C=C1C(C)=C(CC)C4=N1 LLDZJTIZVZFNCM-UHFFFAOYSA-J 0.000 abstract 1
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 abstract 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 abstract 1
- 229950003776 protoporphyrin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93882286A | 1986-12-08 | 1986-12-08 | |
| US07/125,011 US4782049A (en) | 1986-12-08 | 1987-12-02 | Tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis |
| PCT/US1987/003248 WO1988004174A1 (en) | 1986-12-08 | 1987-12-07 | Use of tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3770465D1 true DE3770465D1 (de) | 1991-07-04 |
Family
ID=26823181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8888900434T Expired - Lifetime DE3770465D1 (de) | 1986-12-08 | 1987-12-07 | Verwendung von zinn-protoporphyrin und zinn-mesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4782049A (de) |
| EP (1) | EP0295280B1 (de) |
| JP (1) | JPH01501627A (de) |
| KR (1) | KR920002330B1 (de) |
| AT (1) | ATE63815T1 (de) |
| AU (1) | AU597144B2 (de) |
| CA (1) | CA1302253C (de) |
| DE (1) | DE3770465D1 (de) |
| DK (1) | DK443088A (de) |
| IE (1) | IE63507B1 (de) |
| PH (1) | PH25224A (de) |
| WO (1) | WO1988004174A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02501740A (ja) * | 1987-09-08 | 1990-06-14 | ザ ロックフェラー ユニバーシティ | 腫瘍治療における毒性作用を消去するためのメタロポルフィリンの使用 |
| GR1000182B (el) * | 1988-03-28 | 1992-01-20 | Univ Rockefeller | Χρησιμοποιηση πρωτοπορφυρινης κασσιτερου και μεσοπορφυρινης κασσιτερου στην παρασευη φαρμακευτικων συνθεσεων για την αγωγη της ψωριασης. |
| US4997828A (en) * | 1989-02-14 | 1991-03-05 | The Rockefeller University | Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin |
| US5192757A (en) * | 1990-12-20 | 1993-03-09 | Glaxo Inc. | Cobalt porphyrins |
| US5149697A (en) * | 1991-04-18 | 1992-09-22 | Glaxo Inc. | Cobalt porphyrin pharmaceutical compositions |
| WO1995017893A1 (en) * | 1993-12-28 | 1995-07-06 | New York Blood Center | Methods for preventing or treating hiv-1 or hiv-2 infection |
| TW247876B (en) | 1993-12-28 | 1995-05-21 | New York Blood Ct Inc | Pharmaceutical compositions for prevention or treating HIV-1 or HIV-2 infection |
| EP0765161A2 (de) * | 1994-06-02 | 1997-04-02 | Bar-Ilan University | Synergitische Antibiotikazusammensetzungen enthaltend ein Porphyrin und ein Antibiotikum |
| FR2727862B1 (fr) * | 1994-12-07 | 1997-03-28 | Holzmann Stephane | Produits cosmetiques et/ou d'hygiene corporelle et/ou dermatologiques constitues d'une phase aqueuse isotonique et/ou d'une phase aqueuse osmotique |
| WO1997005152A1 (en) * | 1995-08-02 | 1997-02-13 | Warner-Lambert Company | Amino acid complexes of cobalt (iii) mesoporphyrin ix and cobalt (iii) protoporphyrin ix |
| MXPA04012045A (es) * | 2002-06-04 | 2005-08-16 | Wellspring Pharmaceutical Corp | Preparacion de compuestos de haluro de metal mesoporfirina. |
| US7375216B2 (en) * | 2002-06-04 | 2008-05-20 | Infacare Pharmaceutical Corporation | Preparation of metal mesoporphyrin compounds |
| US20040097481A1 (en) * | 2002-11-20 | 2004-05-20 | Benjamin Levinson | Water-soluble mesoporphyrin compounds and methods of preparation |
| US20060222668A1 (en) * | 2005-04-01 | 2006-10-05 | Wellspring Pharmaceutical Corporation | Stannsoporfin compositions, drug products and methods of manufacture |
| WO2008045377A2 (en) * | 2006-10-04 | 2008-04-17 | Infacare Pharmaceutical Corporation | High-purity large-scale preparation of stannsoporfin |
| HUE032290T2 (en) | 2011-03-30 | 2017-09-28 | Infacare Pharmaceutical Corp | Methods for producing metal mesoporphyrins |
| US10639321B2 (en) | 2014-09-29 | 2020-05-05 | Fred Hutchinson Cancer Research Center | Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4454152A (en) * | 1980-05-07 | 1984-06-12 | Hoffmann-La Roche Inc. | Methoxsalen dosage forms |
| US4657902A (en) * | 1985-03-25 | 1987-04-14 | The Rockefeller University | Therapeutic use of tin mesoporphyrin |
| US4692439A (en) * | 1986-06-20 | 1987-09-08 | The Rockefeller University | Therapeutic use of tin diiododeuteroporphyrin |
-
1987
- 1987-12-02 US US07/125,011 patent/US4782049A/en not_active Expired - Lifetime
- 1987-12-07 AU AU10812/88A patent/AU597144B2/en not_active Ceased
- 1987-12-07 KR KR1019880700932A patent/KR920002330B1/ko not_active IP Right Cessation
- 1987-12-07 WO PCT/US1987/003248 patent/WO1988004174A1/en active IP Right Grant
- 1987-12-07 EP EP88900434A patent/EP0295280B1/de not_active Expired - Lifetime
- 1987-12-07 AT AT88900434T patent/ATE63815T1/de not_active IP Right Cessation
- 1987-12-07 JP JP63500719A patent/JPH01501627A/ja active Granted
- 1987-12-07 DE DE8888900434T patent/DE3770465D1/de not_active Expired - Lifetime
- 1987-12-07 CA CA000553714A patent/CA1302253C/en not_active Expired - Lifetime
- 1987-12-08 IE IE332387A patent/IE63507B1/en not_active IP Right Cessation
- 1987-12-08 PH PH36181A patent/PH25224A/en unknown
-
1988
- 1988-08-08 DK DK443088A patent/DK443088A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IE873323L (en) | 1988-06-08 |
| AU597144B2 (en) | 1990-05-24 |
| AU1081288A (en) | 1988-06-30 |
| EP0295280B1 (de) | 1991-05-29 |
| DK443088D0 (da) | 1988-08-08 |
| KR890700026A (ko) | 1989-03-02 |
| ATE63815T1 (de) | 1991-06-15 |
| PH25224A (en) | 1991-03-27 |
| KR920002330B1 (ko) | 1992-03-21 |
| DK443088A (da) | 1988-08-08 |
| EP0295280A4 (de) | 1989-02-21 |
| IE63507B1 (en) | 1995-05-03 |
| EP0295280A1 (de) | 1988-12-21 |
| US4782049A (en) | 1988-11-01 |
| JPH0585523B2 (de) | 1993-12-07 |
| JPH01501627A (ja) | 1989-06-08 |
| WO1988004174A1 (en) | 1988-06-16 |
| CA1302253C (en) | 1992-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3770465D1 (de) | Verwendung von zinn-protoporphyrin und zinn-mesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis. | |
| ATE127342T1 (de) | Verwendung von modafinil zur herstellung eines antiischämischen arzneimittels. | |
| DE69428130T2 (de) | Verwendung von bcl-2 zur herstellung von arzneimitteln zur therapeutischen behandlung und verhinderung von krankheiten | |
| DE69024039T3 (de) | VERWENDUNG VON HYALURONSÄURE IN KOMBINATION MIT ASCORBINSÄURE, ANTITUMORMITTELN UND/ODER NSAIDs ZUR BEHANDLUNG VON KREBS | |
| DE68905205D1 (de) | Verwendung von igf-i zur herstellung eines praeparats fuer die behandlung und die verhuetung von nebeneffekten von hyperinsulinemia bei diabetikern behandelt mit insulin. | |
| DE3881299D1 (de) | Retinoide zur behandlung lichtgeschaedigter haut. | |
| ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
| ATE116848T1 (de) | Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris. | |
| DE69631478D1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
| ATE184193T1 (de) | Verwendung von n-acylaminoalkoholen zur herstellung eines arzneimittels zur behandlung von mastzellerkrankungen | |
| DE69527052D1 (de) | Verwendung von Wasser mit verringertem Deuterium-Gehalt zur Herstellung von hygienischen und kosmetischen Präparaten | |
| ATE99932T1 (de) | Verwendung von pyrrolicloncarbonsaeurealkylestern zur herstellung eines arzneimittels zur behandlung von ichtyosis. | |
| DE69826023D1 (de) | Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome | |
| DE68903840D1 (de) | Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen. | |
| ATE106736T1 (de) | Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes. | |
| DE3781054D1 (de) | Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen. | |
| DE69026511D1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
| MX9304185A (es) | Producto y composicion farmaceutica que lo contiene para el tratamiento de la mastitis y la mestritis bovina. | |
| DE3678113D1 (de) | Verwendung von hyperoxygenierten oelen zur herstellung eines arzneimittells zur behandlung von herpes. | |
| DE69424563T2 (de) | Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis | |
| DE3776170D1 (de) | Quelle ultravioletter strahlen und verwendung derselben in verfahren mit photochemischer reaktion. | |
| DE3686097D1 (de) | Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht. | |
| DE69005113D1 (de) | Verwendung von peroxidlipiden zur herstellung eines arzneimittels zur behandlung von kreislaufinsuffizienz bei lokaler applikation. | |
| ATE69949T1 (de) | Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| DE3784738D1 (de) | Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |